Skip to main content
. 2019 Jul 25;15:1744806919864256. doi: 10.1177/1744806919864256

Table 2.

Kv7 channel activators.

Compound name Kv7 channel subtypes targeted
Acrylamide (S)-1 Kv7.2, 7.3, 7.4, 7.5 and Kv7.2–Kv7.3
Acrylamide (S)-2 Kv7.2
4,4-diisothiocyanatostilbene-2,20-disulfonic acid Kv7.1–KCNE1
Maxipost (BMS-204352) Kv7.2, 7.3, 7.4 and 7.5
Diclofenac Kv7.2, 7.3 and Kv7.2–Kv7.3
Flufenamic acid Kv7.1–KCNE1
Meclofenamic acid Kv7.2, 7.3 and Kv7.2–Kv7.3
Mefenamic acid Kv7.1–KCNE1
NH6 Kv7.2-Kv7.3
Niflumic acid Kv7.1–KCNE1
Retigabine Kv7.2, 7.3, 7.4, 7.5 and Kv7.2–Kv7.3
(Retigabine analog) flupirtine Kv7.2
L-364 373 [(3-R)-1, 3-dihydro-5-(2-fluorophenyl)-3-(1H-indol-3-ylmethyl)-1-methyl-2H-1,4-benzodiazepin-2-one (R-L3) Kv7.1, Kv7.1–KCNE1
Zinc pyrithione Kv7.1, 7.2, 7.4, 7.5 and Kv7.2–Kv7.3